Drug Enforcement Administration December 2007 – Federal Register Recent Federal Regulation Documents

Jon Karl Dively, D.D.S.; Denial of Application
Document Number: E7-25347
Type: Notice
Date: 2007-12-31
Agency: Drug Enforcement Administration, Department of Justice
The Lawsons, Inc., t/a The Medicine Shoppe Pharmacy; Denial of Application
Document Number: E7-25346
Type: Notice
Date: 2007-12-31
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25329
Type: Notice
Date: 2007-12-31
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25114
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: Established Initial Aggregate Production Quotas for 2008
Document Number: E7-25113
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes initial 2008 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA).
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25111
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: E7-25055
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: E7-25054
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25053
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25051
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-25050
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25049
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E7-25048
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-25047
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: E7-25046
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer Of Controlled Substances; Notice Of Application
Document Number: E7-25045
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-25044
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: E7-25043
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: E7-25042
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-25041
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-25040
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: E7-25038
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
Established Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2008
Document Number: 07-6218
Type: Notice
Date: 2007-12-27
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes the initial year 2008 Assessment of Annual Needs for certain List I chemicals in accordance with the Combat Methamphetamine Epidemic Act of 2005 (CMEA), enacted on March 9, 2006.
Reexportation of Controlled Substances
Document Number: E7-24919
Type: Rule
Date: 2007-12-26
Agency: Drug Enforcement Administration, Department of Justice
The Controlled Substances Export Reform Act of 2005 amended the Controlled Substances Import and Export Act to provide authority for the Drug Enforcement Administration (DEA) to authorize the export of controlled substances from the United States to another country for subsequent export from that country to a second country, if certain conditions and safeguards are satisfied. DEA is amending its regulations to implement the new legislation.
MB Wholesale, Inc.; Denial of Application
Document Number: E7-24610
Type: Notice
Date: 2007-12-19
Agency: Drug Enforcement Administration, Department of Justice
Patrick K. Riggs, M.D.; Denial of Application
Document Number: E7-24608
Type: Notice
Date: 2007-12-19
Agency: Drug Enforcement Administration, Department of Justice
Richard Carino, M.D.; Revocation of Registration
Document Number: E7-24606
Type: Notice
Date: 2007-12-19
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E7-24374
Type: Notice
Date: 2007-12-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: E7-23978
Type: Notice
Date: 2007-12-11
Agency: Drug Enforcement Administration, Department of Justice
Designation of Oripavine as a Basic Class of Controlled Substance; Correction
Document Number: E7-23759
Type: Rule
Date: 2007-12-10
Agency: Drug Enforcement Administration, Department of Justice
On September 24, 2007, the Drug Enforcement Administration (DEA) published in the Federal Register a final rule (72 FR 54208) designating oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro- 4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a basic class in schedule II of the Controlled Substances Act (CSA). The drug code for oripavine was inadvertently designated as 9335, a drug code which is already used to identify a schedule I controlled substance. This correction corrects that error and assigns a different drug code to oripavine.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E7-23681
Type: Notice
Date: 2007-12-06
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E7-23680
Type: Notice
Date: 2007-12-06
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: E7-23512
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-23511
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-23510
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-23508
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E7-23480
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Ammar Sabbagh; Denial of Application
Document Number: E7-23476
Type: Notice
Date: 2007-12-04
Agency: Drug Enforcement Administration, Department of Justice
Definition of “Positional Isomer” as It Pertains to the Control of Schedule I Controlled Substances
Document Number: E7-23413
Type: Rule
Date: 2007-12-03
Agency: Drug Enforcement Administration, Department of Justice
On May 25, 2006, DEA published a Notice of Proposed Rulemaking which proposed the addition of a specific definition for the term ``positional isomer'' to allow for the systematic determination of which isomers of schedule I substances would be considered to be ``positional,'' and therefore, subject to schedule I control. This rulemaking finalizes that definition. The Controlled Substances Act (CSA) and its implementing regulations specify which hallucinogenic substances are considered schedule I controlled substances. The CSA states that all salts, isomers, and salts of isomers of these substances are also schedule I controlled substances. In non-technical terms, an isomer of a substance is a different compound, but a compound which has the same number and kind of atoms. The terms ``optical isomer'' and ``geometric isomer'' are specific scientific terms and it is easy to determine whether one substance is an optical or geometric isomer of another. The term ``positional isomer,'' however, is subject to scientific interpretation. The addition of a definition for the term ``positional isomer'' will assist legitimate research[ers] and industry in determining the control status of materials that are ``positional isomers'' of schedule I hallucinogens. While the DEA will remain the authority for ultimately determining the control status of a given material, providing a specific definition for ``positional isomer'' will ensure consistent criteria are utilized in making these determinations. This rule does not change existing laws, regulations, policies, processes, and procedures regarding the determination of control status for schedule I hallucinogenic substances. This rule merely makes available to the public the longstanding definition of ``positional isomer'' which DEA has used when making these scheduling determinations. This rule is relevant only to specialized forensic or research chemists. Most of these individuals are existing DEA registrants who are authorized by the DEA to handle schedule I hallucinogenic substances.